Page 5 - Tempo Smart Button News Today : Breaking News, Live Updates & Top Stories | Vimarsana

What We Should Know:  – Glooko Inc., a provider of remote patient monitoring and data management solutions for diabetes and other chronic conditions announced a strategic collaboration with Eli Lilly and Company for people with diabetes that use Lilly’s connected insulin pen solutions.   – The technology collaboration will ease insulin management for people with diabetes and their healthcare providers in markets outside the U.S., via integration of Lilly’s Tempo Pen™ and Tempo Smart Button™ (currently in late-stage development) with Glooko’s platform. – Glooko’s platforms...

Photo: Martin Barraud/Getty Images Pharma giant Eli Lilly has inked a series of deals with four diabetes management companies to integrate with its forthcoming Tempo Pen and Tempo Smart Button products. The companies that signed strategic international agreements with Eli Lilly are Dexcom, Glooko, myDiabby Healthcare and Roche. Through the agreements, Eli Lilly’s Tempo Pen and connected Tempo Smart Button will integrate with the software platforms and/or medical devices offered by the diabetes management companies to allow for the collection and sharing of personal health data. "We're pleas...

06 maggio 2021 12:51 Fonte: Adnkronos #salute-e-benessere - Roche and Lilly will integrate data from Lilly's connected insulin pen solution into the mySugr app in several countries. - Both companies are dedicated to driving new possibilities to ease the complexity of daily decision making for people with diabetes on insulin pen therapy and their healthcare professionals.  - By collaborating with Lilly, Roche accelerates growth of its open ecosystem enabling its strategy of integrated Personalised Diabetes Management (iPDM). BASEL, Switzerland, May 6, 2021 /PRNewswire/ -- Roche today announ...